Ignite Creation Date:
2024-05-06 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02752685
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-06
First Post:
2016-04-25
Brief Title:
Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
None
Primary Completion Date:
2022-12-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2016-04-25
First Submit QC Date:
April 25 2016
Study First Post Date:
2016-04-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-03-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-08
Last Update Post Date:
2024-03-06
Last Update Post Date Type:
ACTUAL